Clinical outcomes and longitudinal circulating tumor DNA changes after treatment with nivolumab and olaparib in immunotherapy relapsed melanoma with detected homologous recombination deficiency
- Publication date
- 1 January 2021
- Publisher
- Digital Commons@Becker